West Pharmaceutical Services Tax Provision (Benefit) on Currency Translation Adjustment decreased by 85.7% to $100.00K in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 109.1%, from -$1.10M to $100.00K.
Reflects the tax efficiency of managing foreign currency exposures; usually a secondary adjustment to comprehensive income.
Represents the tax impact associated with foreign currency translation adjustments recorded in other comprehensive incom...
Specific to companies with significant international operations and complex tax structures.
tmo_tax_provision_on_currency_translation| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $300.00K | $100.00K | $1.00M | $1.70M | $1.10M | $200.00K | $1.30M | $400.00K | $1.00M | $700.00K | -$2.50M | -$1.10M | -$1.00M | $700.00K | $100.00K |
| QoQ Change | — | -66.7% | +900.0% | +70.0% | -35.3% | -81.8% | +550.0% | -69.2% | +150.0% | -30.0% | -457.1% | +56.0% | +9.1% | +170.0% | -85.7% |
| YoY Change | — | — | — | +466.7% | >999% | -80.0% | -23.5% | -63.6% | +400.0% | -46.2% | -725.0% | -210.0% | -242.9% | +128.0% | +109.1% |